Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000974379 | SCV001122201 | likely benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002503101 | SCV002809632 | likely benign | Type I complement component 8 deficiency | 2022-04-11 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000974379 | SCV001978088 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000974379 | SCV001979999 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003906080 | SCV004720840 | likely benign | C8A-related disorder | 2024-01-12 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |